Novel brain-specific 5-HT4 receptor splice variants show marked constitutive activity: Role of the C-terminal intracellular domain

Molecular Pharmacology

Volumn 55, Issue 5, 1999, Pages 910-920

  Claeysen, Sylvie ^a   Sebben, Michèle ^a   Becamel, Carine ^a   Bockaert, Joël ^a   Dumuis, Aline ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN 4 RECEPTOR;

ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; RECEPTOR AFFINITY;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BRAIN; CELLS, CULTURED; CYCLIC AMP; GENE DELETION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN CONFORMATION; RATS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SEQUENCE HOMOLOGY, AMINO ACID; SEROTONIN;

EID: 0032938367     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. + current in mammalian neurons. Proc Natl Acad Sci USA 92:6635-6639.
2. 4 receptors in neurons. Eur J Pharmacol 298:165-174.
3. Blondel O, Gastineau M, Dahmoune Y, Langlois M and Fischmeister R (1998) Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J Neurochem 70:2252-2261.
4. 4 receptor cloned from human atrium. FEBS Lett 412:465-474.
5. 4 Receptors: An update, in Handbook of Experimental Pharmacology: Serotoninergic Neurons and 5-HT Receptors in the CNS (Baumgarten HG and Gothert M, eds), pp 439-465, Spinger-Verlag, Berlin.
6. Changeux JP and Edelstein SJ (1998) Allosteric receptors after 30 years. Neuron 21:959-980.
7. Chidiac P, Hebert TE, Valiquette M, Dennis M and Bouvier M (1994) Inverse agonist activity of β-adrenergic antagonists. Mol Pharmacol 45:490-499.
8. 4S receptors. Effect of receptor density on their coupling to adenylyl cyclase. Neuroreport 8:3189-3196.
9. Claeysen S, Faye P, Sebben M, Lemaire S, Bockaert J, Dumuis A and Taviaux S (1997b) Assignment of 5-hydroxytryptamine receptor (HTR4) to human chromosome 5 band(s) q31-33 by in situ hybridization. Cytogenet Cell Genet 78:133-134.
10. 4L receptor. FEBS Lett 398:19-25.
11. Costa T and Hertz A (1989) Antagonists with negative intrinsic activity at δ opioid receptors coupled to GTP-binding proteins. Proc Natl Acad Sci USA 86:7321-7325.
12. Cotecchia S, Exum S, Caron MG and Lefkowitz RJ (1990) Regions of the α1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc Natl Acad Sci USA 87:2896-2900.
13. Cotecchia S, Ostrowski J, Kjelsberg J, Caron MG and Lefkowitz RJ (1992) Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem 267:1633-1639.
14. Dumuis A, Bouhelal R, Sebben M, Cory R and Bockaert J (1988) A non classical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880-887.
15. 4 receptors. Trends Pharmacol Sci 16:391-398.
16. Gerald C, Adham N, Kao H-T, Olsen M, Laz TM, Schechter LE, Bard JA, Vaysse PJJ, Hartig PR, Branchek TA and Weinshank RL (1995) The 5-HT4 receptor: Molecular cloning and pharmacological characterization of two splice variants. EMBO J 14:2806-2815.
17. Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H and Kobilka BK (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272:2587-2590.
18. Hasegawa H, Negishi M and Ichikawa A (1996) Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J Biol Chem 271:1857-1860.
19. Hoyer D and Martin G (1997) 5-HT receptor classification and nomenclature: Towards a harmonization with human genome. Neuropharmacology 36:419-428.
20. Journot L, Spengler D, Pantaloni C, Dumuis A, Sebben M and Bockaert J (1994) The PACAP receptor: Generation by alternative splicing of functional diversity among G Protein-coupled receptors in nerve cells. Semin Cell Biol 5:263-272.
21. Kenakin T (1995) Agonist-receptor efficacy. I: Mechanisms of efficacy and receptor promiscuity. Trends Pharmacol Sci 18:188-192.
22. Kenakin T and Weiss J (1996) The evolution of drug-receptor models: The cubic ternary complex model for seven transmembrane domain receptors. Biopharm J 1:3-14.
23. 1B-adrenergic receptor by all amino acid substitutions at a single site. J Biol Chem 267:1430-1433.
24. 4 receptors improve social olfactory memory in the rat. Neuropharmacology 36:681-687.
25. 4 receptors. Neuropharmacology 36:697-706.
26. Mary S, Gomeza J, Prézeau L, Bockaert J and Pin J-P (1998) A cluster of basic residues in the carboxyl-terminal tail of the short metabotropic glutamate receptor 1 variants impairs their coupling to phospholipase C. J Biol Chem 273:425-432.
27. Matus-Leibovitch N, Nussensveig DR, Gershengorn MC and Oron Y (1995) Truncation of the thyrotropin-releasing hormone receptor carboxyl tail causes constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells. J Biol Chem 270:1041-1047.
28. Monod J, Wyman J and Changera J-P (1965) On the nature of allosteric transitions: A plausible model. J Mol Biol 12:88-118.
29. Parker EM and Ross EM (1991) Truncation of the extended carboxyl-terminal domain increases the expression and regulatory activity of the avian β-adrenergic receptor. J Biol Chem 266:9987-9996.
30. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G (1993) Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenoma. Nature (London) 365:649-651.
31. Pei G, Samama P, Lohse M, Wang M, Codina J and Lefkowitz RJ (1994) A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized and phosphorylated. Proc Natl Acad Sci USA 91:2699-2702.
32. Ramsay G, Evan GI and Bishop JM (1984) The protein encoded by the human proto-oncogene c-myc. Prac Natl Acad Sci USA 81:7742-7746.
33. 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 268:4625-4635.
34. Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA, Lentz R, Raab H, Kohr WJ and Goeddel DV (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361-370.
35. Spiegel AM, Weinstein LS and Shenker A (1993) Abnormalities in G protein-coupled signal transduction pathways in human disease. J Clin Invest 92:1119-1125.
36. 4 receptor cDNA. J Neurochem 69:1810-1819.
37. Van Sande J, Parma J, Tonacchera M, Swillens S, Dumont J and Vasaart G (1995) Somatic and germline mutations of the TSH receptor gene in thyroid diseases. J Clin Endocrinol Metab 80:2577-2585.
38. Waeber C, Sebben M, Nieoullon A, Bockaert J and Dumuis A (1994) Regional distribution and ontogeny of 5-HT4 binding sites in rodent brain. Neuropharmacology 33:527-541.
39. Weiss ER, Osawa S, Shi W and Dickerson CD (1994) Effects of carboxyl-terminal truncation on the stability and G protein-coupling activity of bovine rhodopsin. Biochemistry 33:7587-7593.
40. Wicks IP, Wilkinson D, Salvaris E and Boyd AW (1992) Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines. Proc Natl Acad Sci USA 89:1611-1615.